| Patent | Date |
|---|
Single Domain Antibodies Against Cll-1
App 20220112292 - Lobb; Roy ; et al. | 2022-04-14 |
Compositions and methods for tumor transduction
Grant 11,059,904 - Lobb , et al. July 13, 2 | 2021-07-13 |
Compositions And Methods For Treatment Of Cancer
App 20210130494 - Lobb; Roy ; et al. | 2021-05-06 |
Cd19 Variants
App 20210079060 - Lobb; Roy ; et al. | 2021-03-18 |
Compositions And Methods For Tumor Transduction
App 20200306375 - Lobb; Roy ; et al. | 2020-10-01 |
Compositions And Methods For Treatment Of Cancer
App 20200255541 - Kind Code | 2020-08-13 |
Compositions and methods for treatment of cancer
Grant 10,669,349 - Lobb , et al. | 2020-06-02 |
Compositions and methods for treatment of cancer
Grant 10,508,143 - Lobb , et al. Dec | 2019-12-17 |
Compositions And Methods For Tumor Transduction
App 20190112386 - Lobb; Roy ; et al. | 2019-04-18 |
Compositions and methods for tumor transduction
Grant 10,072,094 - Lobb , et al. September 11, 2 | 2018-09-11 |
Compositions and methods for tumor transduction
Grant 10,066,023 - Lobb , et al. September 4, 2 | 2018-09-04 |
Compositions And Methods For Treatment Of Cancer
App 20180142035 - Lobb; Roy ; et al. | 2018-05-24 |
Compositions And Methods For Tumor Transduction
App 20180022821 - Lobb; Roy ; et al. | 2018-01-25 |
Compositions And Methods For Tumor Transduction
App 20170260288 - Lobb; Roy ; et al. | 2017-09-14 |
Taci As An Anti-tumor Agent
App 20150218247 - Ambrose; Christine ; et al. | 2015-08-06 |
Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
Grant 8,440,189 - Rennert May 14, 2 | 2013-05-14 |
Kim-1 Antibodies For Treatment Of Th2-mediated Conditions
App 20130089539 - Rennert; Paul ; et al. | 2013-04-11 |
Taci As An Anti-tumor Agent
App 20120189634 - Ambrose; Christine ; et al. | 2012-07-26 |
KIM-1 antibodies for treatment of TH2-mediated conditions
Grant 8,206,705 - Rennert , et al. June 26, 2 | 2012-06-26 |
Antagonists Of Tweak And Of Tweak Receptor And Their Use To Treat Immunological Disorders
App 20120027751 - Rennert; Paul | 2012-02-02 |
Kim-1 Antibodies For Treatment Of Th2-mediated Conditions
App 20100150905 - Rennert; Paul ; et al. | 2010-06-17 |
Antagonists Of Tweak And Of Tweak Receptor And Their Use To Treat Immunological Disorders
App 20100061985 - Rennert; Paul | 2010-03-11 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies
Grant 7,592,007 - Gribben , et al. September 22, 2 | 2009-09-22 |
Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
Grant 7,579,001 - Rennert August 25, 2 | 2009-08-25 |
Methods of treating a tumor that expresses APRIL by administering BCMA
Grant 7,276,241 - Schneider , et al. October 2, 2 | 2007-10-02 |
Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
App 20070110745 - Rennert; Paul | 2007-05-17 |
Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
Grant 7,169,387 - Rennert January 30, 2 | 2007-01-30 |
Heterologous polypeptide of the TNF family
App 20050124543 - Rennert, Paul ; et al. | 2005-06-09 |
Heterologous polypeptide of the TNF family
Grant 6,875,846 - Rennert , et al. April 5, 2 | 2005-04-05 |
Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
App 20050008636 - Rennert, Paul | 2005-01-13 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies
Grant 6,719,972 - Gribben , et al. April 13, 2 | 2004-04-13 |
Taci as an anti-tumor agent
App 20040013674 - Ambrose, Christine ; et al. | 2004-01-22 |
April receptor (BCMA) and uses thereof
App 20030082175 - Schneider, Pascal ; et al. | 2003-05-01 |
Heterologous polypeptide of the TNF family
App 20030023038 - Rennert, Paul ; et al. | 2003-01-30 |
Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
App 20020015703 - Rennert, Paul | 2002-02-07 |
| 